Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Trends in the Cost of Cancer Care: Beyond Drugs
Aaron A. Laviana et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review
Matthew R. LeBlanc et al.
QUALITY OF LIFE RESEARCH (2020)
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Peter M. Voorhees et al.
BLOOD (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019
Stacie B. Dusetzina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995-2017
Natsuki Takano et al.
LUNG CANCER (2019)
Palliative Care in Patients With Multiple Myeloma
Renato V. Samala et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2019)
Recent updates on CAR T clinical trials for multiple myeloma
Quande Lin et al.
MOLECULAR CANCER (2019)
Integrated outpatient palliative care for patients with advanced cancer: A systematic review and meta-analysis
Jessica J. Fulton et al.
PALLIATIVE MEDICINE (2019)
Living with relapsed myeloma: Symptoms and self-care strategies
Orlaith Cormican et al.
JOURNAL OF CLINICAL NURSING (2018)
NCCN Guidelines (R) Insights Multiple Myeloma, Version 3.2018 Featured Updates to the NCCN Guidelines
Shaji K. Kumar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Systemic Therapy for Colon Cancer
Christina Wu
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
Praful Ravi et al.
BLOOD CANCER JOURNAL (2018)
Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies
Kristen B. McCullough et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
A systematic review of health-related quality of life in longitudinal studies of myeloma patients
Lene Kongsgaard Nielsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Change in Self-as-Context (Perspective-Taking) Occurs in Acceptance and Commitment Therapy for People With Chronic Pain and Is Associated With Improved Functioning
Lin Yu et al.
JOURNAL OF PAIN (2017)
HAEMATOLOGICAL CANCER Where are we now with the treatment of multiple myeloma?
Gareth J. Morgan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent
Paul Richardson et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Posttransplant maintenance therapy in multiple myeloma: the changing landscape
S. Sengsayadeth et al.
BLOOD CANCER JOURNAL (2017)
Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies
Shaji Kumar
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Shahzad Raza et al.
CURRENT CANCER DRUG TARGETS (2017)
Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
Luciano J. Costa et al.
BLOOD ADVANCES (2017)
Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis
Christina Ramsenthaler et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Managing relapsed myeloma: The views of patients, nurses and doctors
Orlaith Cormican et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2016)
Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity
Luciano J. Costa et al.
LEUKEMIA & LYMPHOMA (2016)
Gender differences in associations between cancer-related problems and relationship dissolution among cancer survivors
Cristina Stephens et al.
JOURNAL OF CANCER SURVIVORSHIP (2016)
Health-Related Quality of Life in Older Adult Survivors of Selected Cancers: Data From the SEER-MHOS Linkage
Erin E. Kent et al.
CANCER (2015)
Curing myeloma at last: defining criteria and providing the evidence
Bart Barlogie et al.
BLOOD (2014)
An exploration of the lived experiences of individuals with relapsed Multiple Myeloma
K. Maher et al.
EUROPEAN JOURNAL OF CANCER CARE (2011)
Living with multiple myeloma: experiences of patients and their informal caregivers
Alex Molassiotis et al.
SUPPORTIVE CARE IN CANCER (2011)
Are cancer survivors at an increased risk for divorce? A Danish cohort study
Kathrine Carlsen et al.
EUROPEAN JOURNAL OF CANCER (2007)
Three approaches to qualitative content analysis
HF Hsieh et al.
QUALITATIVE HEALTH RESEARCH (2005)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Share Paper
